PRACTICE + SCIENCE / PRODUCT REFERENCE
Depo-Medrol® vs Solu-Medrol®Similar Names, Different Formulations
A shared base-drug name leaves chemical form and supplied presentation unresolved. Keep both in the product request.
At a glance
What to verify first
- Depo-Medrol® contains methylprednisolone acetate as an injectable suspension. Solu-Medrol® contains methylprednisolone sodium succinate as powder for solution. Their similar names and shared base drug do not establish interchangeable formulations, doses or routes. [1] [2]
Depo-Medrol® contains methylprednisolone acetate as an injectable suspension. Solu-Medrol® contains methylprednisolone sodium succinate as powder for solution. Their similar names and shared base drug do not establish interchangeable formulations, doses or routes. [1] [2]
Clarity at the handoff
Depo-Medrol®: Methylprednisolone acetate. [1]
Solu-Medrol®: Methylprednisolone sodium succinate. [2]
The clinical team responsible for the request confirms the intended formulation before purchasing matches the product.
A request for "methylprednisolone injection" can reach the purchasing team before the intended formulation is clear. Searching the shared name may produce both brands, but the search result cannot make the clinical decision that the request omitted.
The practical comparison begins with the full ingredient name and dosage form. Once the clinical team responsible for the request identifies the intended product, staff can carry that identity into the strength, presentation and package fields. This article follows that clarification using two exact labeled examples; it does not rank the products or choose a treatment.
Fictional clarification scene created with AI. Exact source products are shown separately below.
Start with the complete formulation name
The words following methylprednisolone carry information the shortened request has lost. When a record keeps only the shared drug name, the two formulations become harder to distinguish in a search, a printed request or a later reconciliation. Retain the full name wherever the product is identified.
The Depo-Medrol® label identifies the acetate formulation and a sterile aqueous suspension. The Solu-Medrol® label identifies the sodium succinate formulation and sterile powder. These are product-identity statements, each tied to its own prescribing information. [1] [2]
For an unresolved request, the appropriate question is therefore which full formulation the clinician intended. Asking only which brand is available skips that question. Availability can help locate a specified product; it cannot supply the missing clinical specification.
KEEP THE FULL FORMULATION NAME
DEPO-MEDROL®
Methylprednisolone acetate
Injectable suspension
SOLU-MEDROL®
Methylprednisolone sodium succinate
Sterile powder for solution
Source-bounded names and dosage forms. This split does not authorize substitution, dose conversion or route selection. [1] [2]
Read the supplied form before comparing the numbers
A strength number is meaningful only with its unit and product description attached. Keep the difference between an amount per milliliter and an amount per vial visible. A row that reduces both examples to "40 mg" has discarded information needed to understand the package.
DEPO-MEDROL® / ORIGINAL CLINT PHOTO
SOLU-MEDROL® / ORIGINAL VIAL PANEL
Original source imagery: Clint Pharmaceuticals and manufacturer/labeler artwork hosted by DailyMed.
Two complete formulation identities
Identification field | Selected Depo-Medrol® | Selected Solu-Medrol® |
|---|---|---|
Chemical form | Methylprednisolone acetate | Methylprednisolone sodium succinate |
Supplied dosage form | Injectable suspension | Sterile powder for solution |
Selected strength and presentation | 40 mg/mL; 1 mL single-dose vial | 40 mg per Act-O-Vial®; single-dose |
Selected sale identifier | 0009-3073-01; one 1 mL vial | 0009-0039-28; carton of 25 Act-O-Vial®s |
Depo-Medrol® label restriction: The label states not for intravenous use. [1]
Scope of this comparison: No preparation or dose-equivalence instruction is supplied here. The comparison does not choose a route.
Exact identity comparison. Strengths and forms do not establish substitution or a route choice. Depo-Medrol®: [1] Solu-Medrol®: [2] [3]
Preserve the package level and exact presentation
For the selected Solu-Medrol® example, carton NDC 0009-0039-28 contains 25 of immediate-container NDC 0009-0039-30. The selected 40 mg Act-O-Vial® is labeled preservative-free. Those statements apply to that presentation; the brand label also lists preserved formulations. [2] [3]
SALE CARTON 0009-0039-28
25 Act-O-Vial®s
IMMEDIATE VIAL 0009-0039-30
The two NDCs name different package levels.
Source-bounded crosswalk for the selected 40 mg presentation. [2] [3]
Keep the carton identifier and the container identifier in separate fields. If someone later compares a vial with the purchase record, the difference between the numbers has an explanation. It should not be necessary to guess whether a number was copied incorrectly or whether the product changed.
The same discipline applies to descriptive words. A brand-wide note such as "preservative-free" can outgrow the evidence that originally supported it. Attach any formulation or designation statement to the exact presentation being reviewed, and retain the primary source. A category heading can help someone navigate; it cannot replace that record.
PRACTICE + SCIENCE / VISUAL REFERENCE
Keep the complete formulation name.
Methylprednisolone acetateMethylprednisolone sodium succinateSupplied dosage form
Conceptual artwork created with AI. Two generic sealed vials beside separate navy reference folders. Product identity and instructions come from the cited sources, not this illustration.
Work through an ambiguous request
Suppose an internal request reads "methylprednisolone injection, 40 mg." This is a hypothetical documentation example. It leaves the chemical form, supplied dosage form and intended package unresolved. The presence of a familiar number does not finish the identification.
A useful clarification would be: "Please confirm the intended full product and presentation. The request does not distinguish the acetate suspension from the sodium succinate powder. Please identify the approved product before we match a catalog entry." That response names the missing decision without asking purchasing staff to infer it from the available listings.
From incomplete name to confirmed product record
Keep the original wording: Retain the original wording so the responsible clinical team can see which identity fields are missing. | Return the formulation question: Ask for the full ingredient name, supplied form and approved presentation. Do not select between the comparison columns. | Record the confirmed identity: Copy that team's confirmed decision into the product record, then match strength, package level and identifier. |
Author-created clarification workflow. The two formulation identities come from the product labels. [1] [2] This is not a manufacturer handling procedure.
After the clinical team confirms the product, record its full ingredient name, supplied form, labeled strength, presentation and relevant NDC. Keep the labeled package count separate from the supplier's ordering unit. If a package detail remains unclear, ask about that field; if the formulation changes, return the proposed change to the clinical team.
Clint product reference
Once the clinical team confirms the intended formulation, open the matching Depo-Medrol® or Solu-Medrol® category at Clint. Preserve the complete product description and package identifier through ordering, and confirm the supplied quantity and current availability.
Sources and scope
- Pfizer Depo-Medrol® single-dose vial label. Description, How Supplied and single-dose/non-intravenous designation. Revised November 2025.
- Pfizer Solu-Medrol® label. Description and How Supplied. Revised November 2025.
- Solu-Medrol® label and package display panels on DailyMed. 40 mg vial and carton panels; packaging crosswalk. Body revised November 2025; page updated December 2, 2025. Pharmacia & Upjohn Company LLC is identified as packager.
- Clint Depo-Medrol® listings. Catalog navigation only; checked October 5, 2026.
- Clint Solu-Medrol® listings. Catalog navigation only; checked October 5, 2026.
Sources rechecked October 5, 2026. This is a product-identification reference; clinical decisions require the complete current labeling and the responsible clinical team.